OraSure Technologies Current Ratio 2010-2025 | OSUR
OraSure Technologies current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| OraSure Technologies Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.31B | $0.03B | 12.34 |
| 2024-12-31 | $0.33B | $0.03B | 9.95 |
| 2024-09-30 | $0.35B | $0.03B | 12.60 |
| 2024-06-30 | $0.35B | $0.03B | 12.17 |
| 2024-03-31 | $0.35B | $0.03B | 11.97 |
| 2023-12-31 | $0.39B | $0.04B | 9.78 |
| 2023-09-30 | $0.36B | $0.04B | 8.71 |
| 2023-06-30 | $0.34B | $0.05B | 7.36 |
| 2023-03-31 | $0.34B | $0.06B | 6.23 |
| 2022-12-31 | $0.33B | $0.07B | 4.71 |
| 2022-09-30 | $0.28B | $0.07B | 3.90 |
| 2022-06-30 | $0.27B | $0.07B | 4.08 |
| 2022-03-31 | $0.27B | $0.06B | 4.83 |
| 2021-12-31 | $0.30B | $0.07B | 4.40 |
| 2021-09-30 | $0.29B | $0.05B | 5.34 |
| 2021-06-30 | $0.29B | $0.05B | 6.12 |
| 2021-03-31 | $0.29B | $0.05B | 6.55 |
| 2020-12-31 | $0.29B | $0.05B | 6.21 |
| 2020-09-30 | $0.30B | $0.04B | 8.14 |
| 2020-06-30 | $0.32B | $0.03B | 10.40 |
| 2020-03-31 | $0.22B | $0.03B | 8.48 |
| 2019-12-31 | $0.23B | $0.03B | 6.86 |
| 2019-09-30 | $0.22B | $0.03B | 7.72 |
| 2019-06-30 | $0.21B | $0.03B | 6.99 |
| 2019-03-31 | $0.21B | $0.03B | 7.52 |
| 2018-12-31 | $0.22B | $0.03B | 7.84 |
| 2018-09-30 | $0.21B | $0.02B | 9.71 |
| 2018-06-30 | $0.20B | $0.02B | 9.58 |
| 2018-03-31 | $0.20B | $0.02B | 9.29 |
| 2017-12-31 | $0.22B | $0.03B | 6.88 |
| 2017-09-30 | $0.21B | $0.03B | 7.86 |
| 2017-06-30 | $0.21B | $0.02B | 8.87 |
| 2017-03-31 | $0.18B | $0.02B | 9.88 |
| 2016-12-31 | $0.16B | $0.02B | 9.03 |
| 2016-09-30 | $0.15B | $0.02B | 6.87 |
| 2016-06-30 | $0.15B | $0.03B | 5.61 |
| 2016-03-31 | $0.13B | $0.02B | 6.60 |
| 2015-12-31 | $0.14B | $0.03B | 5.42 |
| 2015-09-30 | $0.14B | $0.03B | 4.78 |
| 2015-06-30 | $0.13B | $0.02B | 8.03 |
| 2015-03-31 | $0.12B | $0.02B | 7.03 |
| 2014-12-31 | $0.13B | $0.03B | 4.96 |
| 2014-09-30 | $0.13B | $0.03B | 5.15 |
| 2014-06-30 | $0.12B | $0.02B | 7.87 |
| 2014-03-31 | $0.11B | $0.02B | 7.47 |
| 2013-12-31 | $0.12B | $0.02B | 6.30 |
| 2013-09-30 | $0.11B | $0.02B | 5.76 |
| 2013-06-30 | $0.11B | $0.02B | 6.74 |
| 2013-03-31 | $0.11B | $0.02B | 6.28 |
| 2012-12-31 | $0.12B | $0.02B | 7.22 |
| 2012-09-30 | $0.12B | $0.02B | 7.27 |
| 2012-06-30 | $0.05B | $0.02B | 2.52 |
| 2012-03-31 | $0.05B | $0.02B | 2.61 |
| 2011-12-31 | $0.05B | $0.02B | 2.40 |
| 2011-09-30 | $0.05B | $0.02B | 2.34 |
| 2011-06-30 | $0.10B | $0.02B | 4.84 |
| 2011-03-31 | $0.09B | $0.02B | 5.17 |
| 2010-12-31 | $0.10B | $0.02B | 4.95 |
| 2010-09-30 | $0.10B | $0.02B | 5.26 |
| 2010-06-30 | $0.10B | $0.02B | 4.53 |
| 2010-03-31 | $0.10B | $0.01B | 8.48 |
| 2009-12-31 | $0.11B | $0.02B | 6.81 |
| 2009-09-30 | $0.11B | $0.01B | 7.60 |
| 2009-06-30 | $0.10B | $0.01B | 9.23 |
| 2009-03-31 | $0.10B | $0.01B | 8.98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.225B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.464B | 25.98 |
| Boston Scientific (BSX) | United States | $155.948B | 37.25 |
| Stryker (SYK) | United States | $144.198B | 29.40 |
| EssilorLuxottica (ESLOY) | France | $136.878B | 0.00 |
| Medtronic (MDT) | Ireland | $114.582B | 16.24 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.915B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.396B | 24.77 |
| ResMed (RMD) | United States | $40.938B | 29.24 |
| Agilent Technologies (A) | United States | $32.241B | 21.02 |
| GE HealthCare Technologies (GEHC) | United States | $31.891B | 14.99 |
| Koninklijke Philips (PHG) | Netherlands | $25.479B | 16.85 |
| Terumo (TRUMY) | Japan | $25.170B | 32.69 |
| Insulet (PODD) | United States | $20.051B | 78.70 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.929B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.503B | 0.00 |
| Baxter (BAX) | United States | $11.269B | 8.71 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.745B | 28.29 |
| Lantheus Holdings (LNTH) | United States | $4.882B | 12.32 |
| Perrigo (PRGO) | Ireland | $3.662B | 9.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.643B | 16.27 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Envista Holdings (NVST) | United States | $3.530B | 24.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.136B | 23.12 |
| LeMaitre Vascular (LMAT) | United States | $1.831B | 40.93 |
| AtriCure (ATRC) | United States | $1.710B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.543B | 10.61 |
| Green Thumb Industries (GTBIF) | United States | $1.429B | 32.14 |
| Acuren (TIC) | United States | $1.340B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Phibro Animal Health (PAHC) | United States | $1.058B | 13.53 |
| Neogen (NEOG) | United States | $1.012B | 16.07 |
| BioLife Solutions (BLFS) | United States | $0.995B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.868B | 8.04 |
| Kestra Medical Technologies (KMTS) | United States | $0.790B | 0.00 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.572B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 20.39 |
| Surmodics (SRDX) | United States | $0.515B | 0.00 |
| CeriBell (CBLL) | United States | $0.511B | 0.00 |
| Owens & Minor (OMI) | United States | $0.508B | 4.21 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.361B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.311B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.304B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.296B | 10.88 |
| Quanterix (QTRX) | United States | $0.293B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.239B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.234B | 19.77 |
| Omeros (OMER) | United States | $0.223B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.35 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.215B | 0.00 |
| Biote (BTMD) | United States | $0.213B | 5.98 |
| Vireo Growth (VREOF) | United States | $0.196B | 0.00 |
| Exagen (XGN) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.69 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| Safety Shot (SHOT) | United States | $0.122B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.45 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.51 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Zynex (ZYXI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.71 |
| Nephros (NEPH) | United States | $0.036B | 48.86 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |